Overview of Dr. Grisham
Dr. Rachel Grisham is an oncologist in West Harrison, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Duke University School of Medicine and has been in practice 11 years. Dr. Grisham accepts several types of health insurance, listed below. She is one of 495 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 80 publications and over 500 citings.
Office
500 Westchester Avenue
West Harrison, NY 10604
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
- Duke University School of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2009 - 2026
- CT State Medical License 2023 - 2025
- NJ State Medical License 2019 - 2025
- NC State Medical License 2020 - 2022
- MA State Medical License 2008 - 2009
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies Start of enrollment: 2013 Nov 05
- A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone Start of enrollment: 2019 May 02
- A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer Start of enrollment: 2020 May 07
- Join now to see all
Publications & Presentations
PubMed
- 81 citationsOvarian cancer mutational processes drive site-specific immune evasion.Ignacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, Jamie L P Lim, Michelle Wu
Nature. 2022-12-01 - 182 citationsGermline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.Panagiotis A. Konstantinopoulos, Barbara M. Norquist, Christina Lacchetti, Deborah K. Armstrong, Rachel N. Grisham
Journal of Clinical Oncology. 2020-01-27 - 357 citationsOvarian cancer, version 2.2020Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht
Journal of the National Comprehensive Cancer Network. 2021-02-02
Press Mentions
- Updated Data from Part a of Verastem Oncology's RAMP 201 Trial Show an Objective Response Rate of 45% in Patients with Recurrent Low-Grade Serous Ovarian Cancer Treated with Avutometinib and DefactinibMay 25th, 2023
- Targeting Progesterone in Hormonally Responsive Ovarian CancerDecember 10th, 2019
- Context Therapeutics and World-Renowned Cancer Center Announce a Phase 2 Trial for Apristor® in Progesterone Receptor Positive Gynecological CancersMay 2nd, 2019
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
Empire BCBS HMO
Empire BCBS PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPOMultiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: